December 5, 2012 / 1:55 PM / 5 years ago

BRIEF-Peregrine Pharma up in premarket after announcing progress in advancing Cotara program

1 Min Read

NEW YORK, Dec 5 (Reuters) - Peregrine Pharmaceuticals Inc : * Peregrine Pharma up 20.2 percent to $1.55 in premarket after company announces progress in advancing its Cotara program into a phase III trial

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below